Gastro-enteropancreatic Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Gastro-enteropancreatic Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2022-03-04Clinical Trial Update: Pasireotide Treatment for Neuroendocrine Tumor [Phase 4]
Phase 4 trial of pasireotide for gastro-enteropancreatic neuroendocrine tumor was withdrawn.